Glaxosmithkline Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Glaxosmithkline Phar	Gland Pharma	Ajanta Pharma
Operational Metrics
Pharmaceuticals
Domestic Sales Growth - YoY	8.9 %	n/a	7.5 %
R&D as a % of Total Sales	0.07 %	4.0 %	5.0 %
Financials
5 yr Average ROE	45.03 %	12.02 %	21.93 %
5yr average Equity Multiplier	1.87	1.15	1.33
5yr Average Asset Turnover Ratio	0.92	0.51	0.86
5yr Avg Net Profit Margin	27.88 %	20.79 %	19.12 %
Price to Book	18.41	3.96	9.42
P/E	40.28	39.94	40.4
5yr Avg Cash Conversion Cycle	-107.65 Days	69.81 Days	-104.16 Days
Inventory Days	47.69 Days	118.26 Days	45.5 Days
Days Receivable	24.45 Days	99.92 Days	49.07 Days
Days Payable	155.09 Days	107.43 Days	180.12 Days
5yr Average Interest Coverage Ratio	556.84	183.05	103.83
5yr Avg ROCE	48.35 %	16.55 %	28.04 %
5yr Avg Operating Profit Margin	27.99 %	29.26 %	25.85 %
5 yr average Debt to Equity	0.0	0.01	0.01
5yr CAGR Net Profit	-9.37 %	-6.87 %	8.18 %
5yr Average Return on Assets	24.4 %	10.65 %	16.5 %
Shareholdings
Promoter Holding	75.0 %	51.83 %	63.48 %
Share Pledged by Promoters	0.0	0.0	22.53 %
Change in Promoter Holding (3 Yrs)	0.0	-6.03 %	-2.73 %
Change in Mutual Fund Holding (3 Yrs)	0.62 %	11.53 %	5.03 %

	Glaxosmithkline Phar	Gland Pharma	Ajanta Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 76.0 Vaccines 24.0 Injectables 0 Pharmaceutical products 0	Product Wise Break-Up Pharmaceutical 0 Vaccines 0 Injectables 0 Pharmaceutical products 0 Others 100	Product Wise Break-Up Pharmaceutical 0 Vaccines 0 Injectables 0 Pharmaceutical 100.0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 30.55 Anti-Infective 22.25 Vaccines 12.64 Pain Management 11.96 Hormones 8.91 Vitamins / Minerals / Nutrients 6.47 Respiratory 3.95 Others 3.27	-	Therapeutic Area Wise Break-Up - Domestic Vaccines 0 Anti-Infective 0 Dermatology 22.0 Vitamins / Minerals / Nutrients 0 Hormones 0 Respiratory 0 Pain Management 0 Others 78.0
Location Wise Break-Up	Location Wise Break-Up India 98.64 Rest of the World 1.36 Core Markets 0 Canada, Australia & New Zealand 0 Australia 0 Canada 0 Europe 0 USA 0 Asia 0 Africa 0	Location Wise Break-Up Africa 0 USA 56.27 Core Markets 71.57 Asia 0 Rest of the World 0 Australia 0 Europe 21.88 Canada, Australia & New Zealand 3.37 Canada 0 India 3.84	Location Wise Break-Up Africa 16.28 USA 35.74 Core Markets 0 Asia Pacific 19.39 Rest of the World 0 Australia 0 Europe 0 Canada, Australia & New Zealand 0 Canada 0 India 28.59
Acute vs Chronic	Acute vs Chronic Acute 99.0 Chronic 1.0	-	-